Frontiers in ribonucleotide reductases: nucleotide-dependent control of quaternary structure and enzyme activity

Yimon Aye
2019
Conference Papers

Source officielle

À propos
Confidentialité
Mentions légales

Graph Chatbot

Yimon Aye
2019
Conference Papers

Source officielle

Publications associées (6)

Afficher plus

https://infoscience.epfl.ch/entities/publication/0798b570-c360-4a2d-b0c9-74b5ff70d9f1

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (6)

Afficher plus

Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing

Florian Maria Wurm

Recombinant proteins have been produced for over 30 years. Applications range from enzymes used in laundry detergents to antigen-detecting antibodies in cancer therapy. Despite similarities in manufacturing, drastic differences in retail pricing between re ...

2019

An evolutionarily conserved role for the aryl hydrocarbon receptor in the regulation of movement

Johan Auwerx, Bart Deplancke, Laurent Mouchiroud, Evan Graehl Williams, Pénélope Andreux, Michael Vincent Frochaux

The BXD genetic reference population is a recombinant inbred panel descended from crosses between the C57BL/6 (B6) and DBA/2 (D2) strains of mice, which segregate for about 5 million sequence variants. Recently, some of these variants have been established ...

Public Library of Science2014

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Andrea Pfeifer

Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers, are very productive. The review "Drugs interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs" was accepted in October 2012. In the l ...

Ios Press2014